Financial Consulate Inc Portfolio Analysis: Q2 2026 Investment Trends
A detailed analysis of Financial Consulate, Inc's portfolio changes during the second quarter of 2026.
Financial Consulate, Inc saw significant shifts in its investment strategy during the second quarter of 2026. The firm demonstrated strong conviction in certain sectors while strategically reducing exposure to others.
Prominent Purchases: Growth and ETF Focus
The investor's portfolio allocation increased notably for SCHWAB STRATEGIC TR (SCHF), which now represents 5.93% of the total value, up by 3.71% from Q1. This ETF also saw a substantial increase in shares held.
Financial Consulate Inc significantly boosted its position in SCHWAB STRATEGIC TR (SCHX), maintaining it at 17.25% allocation but increasing the share count by 1.44%. Similarly, DIMENSIONAL ETF TRUST (DUHP) remained a core holding at 9.8%, with shares growing slightly and its percentage allocation rising modestly.
The investor also showed renewed interest in SCHWAB STRATEGIC TR (FNDB), increasing the share count by 3.8% while holding it at 3.66%. Furthermore, PIMCO EQUITY SER (MFDX) allocation grew to 7.9%, up by 1.1% from the previous quarter.
Strategic Additions: ETFs and Specific Sectors
The investor continued to diversify its holdings through exchange-traded funds, increasing exposure in VANGUARD MALVERN FDS (VTIP) which now stands at 4.13%. DIMENSIONAL ETF TRUST (DIHP), holding 4.94% of the portfolio, also saw an increase in shares.
A particularly noteworthy addition was VANGUARD WORLD FD (VGT) at 0.22%. This allocation increased dramatically by 725% during the quarter, indicating a targeted investment in global equities.
Significant Sales: ETF Reductions
The investor made substantial adjustments to its portfolio structure through sales activities. SCHWAB STRATEGIC TR (SCHX) saw an increase despite being one of the largest holdings, while other SCHWAB funds were actively purchased.
A major shift occurred with SPDR INDEX SHS FDS (SPGM), which was completely divested from the portfolio following a 61.3% reduction in shares during Q2. This suggests a deliberate move away from index tracking stocks at this level.
Other Reductions and Specific Sales
The investor also reduced its position in PGIM ETF TR (PULS) by approximately 7.9%, down to 2.36%. Additionally, the firm sold shares of 10X GENOMICS INC (TXG), a stock categorized under Healthcare, reducing its allocation from 0.54% to zero.
No Disclosures for Certain Categories
The provided data does not indicate any changes in the investor's holdings of stocks categorized under sectors like Technology, Financial Services, or Industrials during this period. Similarly, there are no disclosures regarding specific large buy or sell transactions outside those tracked.